Double Medical Technology Inc
SZSE:002901
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/S
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Valuation Scenarios
If P/S returns to its 3-Year Average (8.2), the stock would be worth ¥49.46 (14% upside from current price).
| Scenario | P/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 7.2 | ¥43.4 |
0%
|
| 3-Year Average | 8.2 | ¥49.46 |
+14%
|
| 5-Year Average | 8.6 | ¥51.78 |
+19%
|
| Industry Average | 4.4 | ¥26.38 |
-39%
|
| Country Average | 2.8 | ¥16.57 |
-62%
|
Forward P/S
Today’s price vs future revenue
| Today's Market Cap | Revenue | Forward P/S | ||
|---|---|---|---|---|
|
¥19.9B
|
/ |
Oct 2025
¥2.5B
|
= |
|
|
¥19.9B
|
/ |
Dec 2025
¥2.8B
|
= |
|
|
¥19.9B
|
/ |
Dec 2026
¥3.2B
|
= |
|
|
¥19.9B
|
/ |
Dec 2027
¥3.8B
|
= |
|
Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | P/S | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
|
Double Medical Technology Inc
SZSE:002901
|
18B CNY | 7.2 | 33.2 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
162.6B USD | 16.1 | 56.9 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
155.4B USD | 3.4 | 24.8 | |
| US |
|
Stryker Corp
NYSE:SYK
|
112.7B USD | 4.5 | 34.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
102.7B USD | 2.9 | 22.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
83.8B USD | 4.1 | 23.5 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.8B USD | 7.7 | 44.5 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
39.3B EUR | 1.7 | 18.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.2B USD | 10.5 | 42.7 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
42.5B USD | 1.9 | 24.2 | |
| US |
|
Resmed Inc
NYSE:RMD
|
29.9B USD | 5.5 | 20.1 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.5 |
| Median | 2.8 |
| 70th Percentile | 5.4 |
| Max | 5 034 353.9 |
Other Multiples
Double Medical Technology Inc
Glance View
Double Medical Technology Inc., founded in 2004, has carved a niche for itself as a powerhouse in the medical device sector, particularly focusing on orthopedic solutions. The company operates with an unwavering commitment to innovation, seeking to enhance patient outcomes through state-of-the-art medical technology. Headquartered in Xiamen, China, Double Medical has grown rapidly, leveraging its extensive research and development capabilities to stay ahead in the fast-paced world of medical science. Its diversified product portfolio includes spinal implants, trauma devices, and various orthopedic surgical tools, all crafted with precision to meet the evolving needs of medical professionals around the globe. Earning its revenue primarily from the sale of these products, Double Medical has deftly tapped into the growing demand for advanced healthcare solutions driven by an aging global population and increasing rates of orthopedic conditions. By adhering to international quality standards and obtaining necessary certifications, the company has successfully expanded its footprint beyond China, penetrating markets across Europe, Asia, and beyond. Through strategic partnerships, a robust supply chain, and a focus on customer satisfaction, Double Medical Technology Inc. continues to fortify its position as a leader in the medical device industry, capitalizing on both technological advancements and the ever-present demand for effective orthopedic medical solutions.
